abstract |
A pharmaceutical formulation comprising umirolimus encapsulated in a polymeric micelle, and a pharmaceutically acceptable excipient, carrier, or diluent, wherein the polymeric micelle includes a two-armed block copolymer, the block copolymer being polyethylene glycol-polylactide (PEGPLA), and umirolimus is present in 5-40% by weight of the polymeric micelle. |